New York, NY, United States of America

Boris Pasche

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Symtonic, S.a., Therabionic, Inc., Other. Active years: 1995-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boris Pasche. Retrieved from https://idiyas.com/inventor/boris-pasche

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 80.0


 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 89(Granted Patents)


Location History:

  • New York, NY (US) (1995 - 1997)
  • Chicago, IL (US) (2013)
  • Mountain Brook, AL (US) (2015)

Company Filing History:


Years Active: 1995-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Boris Pasche

Introduction

Boris Pasche is a notable inventor based in New York, NY (US), recognized for his significant contributions to the field of biomedical engineering. He holds a total of 5 patents, showcasing his innovative spirit and dedication to advancing technology in healthcare.

Latest Patents

Among his latest patents is an electronic system for influencing cellular functions in a warm-blooded mammalian subject. This electronic system, activatable by electrical power, is designed to influence cellular functions or malfunctions. It includes controllable low energy high-frequency carrier signal generator circuits, data processors for receiving control information, and amplitude modulation control generators. The system is engineered to accurately control the frequency of amplitude modulations with high precision.

Another significant patent addresses TGFBR1 expression and its role in modifying the risk for colorectal cancer. This invention provides methods for assessing genetic susceptibility to cancer by measuring allele-specific expression or the presence of at-risk haplotypes of TGFBR1. The methods also include screening for agents that modify the expression of TGFBR1, which could lead to advancements in cancer prevention and treatment.

Career Highlights

Boris Pasche has worked with several companies throughout his career, including Symtonic, S.A. and Therabionic, Inc. His work in these organizations has contributed to the development of innovative technologies aimed at improving health outcomes.

Collaborations

Throughout his career, Boris has collaborated with notable individuals such as Alexandre Barbault and Rea-Woun Chang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in technology.

Conclusion

Boris Pasche's contributions to the field of biomedical engineering through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovations that can significantly impact healthcare and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…